Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 234 Breast Neoplasms 234 Prostatic Neoplasms 172 Multiple Myeloma 154 Neoplasms 135 Colorectal Neoplasms 126 Leukemia, Myeloid, Acute 123 Lung Neoplasms 109 Neoplasm Metastasis 101 Squamous Cell Carcinoma of Head and Neck 94 Carcinoma, Hepatocellular 91 Melanoma 89 Lymphoma 85 Triple Negative Breast Neoplasms 77 Pancreatic Neoplasms 76 Ovarian Neoplasms 72 Sarcoma 71 Brain Neoplasms 66 Lymphoma, Large B-Cell, Diffuse 65 Carcinoma, Renal Cell 65 Recurrence 63 Precursor Cell Lymphoblastic Leukemia-Lymphoma 60 Head and Neck Neoplasms 56 Lymphoma, Non-Hodgkin 55 Leukemia, Lymphocytic, Chronic, B-Cell 55 Stomach Neoplasms 52 Hematologic Neoplasms 52 Endometrial Neoplasms 52 Urinary Bladder Neoplasms 51 Rectal Neoplasms 50

Interventions

ribociclib 1 Letrozole 1 Goserelin 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × HER2 Negative Breast Cancer × 90 days × Clear all

NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡